Nu Skin Enterprises Gestione

Gestione criteri di controllo 2/4

Nu Skin Enterprises Il CEO è Ryan Napierski, nominato in Mar2017, e ha un mandato di 7.67 anni. la retribuzione annua totale è $ 5.84M, composta da 17% di stipendio e 83% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.21% delle azioni della società, per un valore di € 750.95K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 12.1 anni e 12.1 anni.

Informazioni chiave

Ryan Napierski

Amministratore delegato

US$5.8m

Compenso totale

Percentuale dello stipendio del CEO	17.0%
Mandato del CEO	7.7yrs
Proprietà del CEO	0.2%
Durata media del management	12.1yrs
Durata media del Consiglio di amministrazione	12.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Ryan Napierski rispetto agli utili di Nu Skin Enterprises?
Data	Compenso totale	Stipendio	Guadagni aziendali
Sep 30 2024	n/a	n/a	-US$103m
Jun 30 2024	n/a	n/a	-US$148m
Mar 31 2024	n/a	n/a	-US$3m
Dec 31 2023	US$6m	US$992k	US$9m
Sep 30 2023	n/a	n/a	US$59m
Jun 30 2023	n/a	n/a	US$70m
Mar 31 2023	n/a	n/a	US$77m
Dec 31 2022	US$5m	US$942k	US$105m
Sep 30 2022	n/a	n/a	US$38m
Jun 30 2022	n/a	n/a	US$113m
Mar 31 2022	n/a	n/a	US$139m
Dec 31 2021	US$5m	US$801k	US$147m
Sep 30 2021	n/a	n/a	US$230m
Jun 30 2021	n/a	n/a	US$237m
Mar 31 2021	n/a	n/a	US$219m
Dec 31 2020	US$4m	US$721k	US$191m
Sep 30 2020	n/a	n/a	US$158m
Jun 30 2020	n/a	n/a	US$146m
Mar 31 2020	n/a	n/a	US$150m
Dec 31 2019	US$2m	US$688k	US$174m
Sep 30 2019	n/a	n/a	US$116m
Jun 30 2019	n/a	n/a	US$125m
Mar 31 2019	n/a	n/a	US$129m
Dec 31 2018	US$3m	US$621k	US$122m
Sep 30 2018	n/a	n/a	US$158m
Jun 30 2018	n/a	n/a	US$146m
Mar 31 2018	n/a	n/a	US$137m
Dec 31 2017	US$3m	US$594k	US$129m

Compensazione vs Mercato: La retribuzione totale di Ryan ($USD 5.84M ) è superiore alla media delle aziende di dimensioni simili nel mercato German ($USD 995.28K ).

Compensazione vs guadagni: La retribuzione di Ryan è aumentata nonostante l'azienda non sia redditizia.

AMMINISTRATORE DELEGATO

Ryan Napierski (50 yo)

7.7yrs

Mandato

US$5,838,579

Compensazione

Mr. Ryan S. Napierski has been Chief Executive Officer of Nu Skin Enterprises Inc. since September 1, 2021. Mr. Napierski has been the President of Nu Skin Enterprises Inc. since March 7, 2017 and has been...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Steven Lund	Co-Founder & Executive Chairman of the Board	28.8yrs	US$856.61k	0.24% € 859.1k
Ryan Napierski	President	7.7yrs	US$5.84m	0.21% € 750.9k
James Thomas	Executive VP	5.3yrs	US$1.86m	0.14% € 518.9k
Joseph Chang	Executive VP & Chief Scientific Officer	18.8yrs	US$1.12m	0.19% € 666.2k
Chayce Clark	Executive VP & General Counsel	3.3yrs	US$2.28m	0.32% € 1.1m
Steve Hatchett	Executive VP & Chief Product Officer	6.8yrs	US$1.41m	0.19% € 692.9k
Blake Roney	Founder	40.8yrs	US$621.69k	Nessun dato
Sandra Tillotson	Founder	28.8yrs	US$1.06m	Nessun dato
Joe Sueper	Senior VP & CTO	3.8yrs	Nessun dato	Nessun dato
Mark Adams	Chief Information Officer	18.8yrs	Nessun dato	Nessun dato
Scott Pond	Vice President of Investor Relations	no data	Nessun dato	Nessun dato
Ashok Pahwa	Chief Marketing Officer	16.5yrs	Nessun dato	Nessun dato

12.1yrs

Durata media

66yo

Età media

Gestione esperta: Il team dirigenziale di NUS è esperto e expertise (durata media dell'incarico 12.1 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Steven Lund	Co-Founder & Executive Chairman of the Board	28.8yrs	US$856.61k	0.24% € 859.1k
Ryan Napierski	President	3.4yrs	US$5.84m	0.21% € 750.9k
Edwina Woodbury	Independent Director	9.4yrs	US$273.20k	0.033% € 118.5k
Daniel Campbell	Lead Independent Director	27.7yrs	US$280.20k	0.21% € 761.7k
Lars Bohlin	Member of Anti-Aging Scientific Advisory Board	no data	Nessun dato	Nessun dato
Thomas Pisano	Independent Director	16.4yrs	US$257.08k	0.15% € 520.1k
Zoe Draelos	Member of the Anti-Aging Scientific Advisory Board	14.8yrs	Nessun dato	Nessun dato
Paul Cox	Member of Anti-Aging Scientific Advisory Board	no data	Nessun dato	Nessun dato
Tomas Prolla	Member of Anti-aging Scientific Advisory Board	15.1yrs	Nessun dato	Nessun dato
Zheqing Shen	Director	8.3yrs	US$249.20k	0.044% € 157.6k
Laura Nathanson	Independent Director	5.4yrs	US$268.20k	0.044% € 155.9k
Emma Battle	Independent Director	3.4yrs	US$264.33k	0.039% € 138.5k

12.1yrs

Durata media

67.5yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di NUS è composto da personale esperto e esperto (durata media dell'incarico 12.1 anni).

Nu Skin Enterprises Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Nu Skin Enterprises Appoints Mark A. Zorko to its Board of Directors and Audit Committee and Nominating and Corporate Governance Committee

Insufficient new directors

Nu Skin Enterprises, Inc., Annual General Meeting, Jun 05, 2024

Independent Director recently sold €254k worth of stock

Nu Skin Enterprises, Inc. Appoints James D. Thomas as Chief Financial Officer

Chief Accounting Officer recently sold €110k worth of stock

Recent updates

Third quarter dividend of US$0.06 announced

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on December 11, 2024

Third quarter 2024 earnings released: EPS: US$0.17 (vs US$0.74 loss in 3Q 2023)

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024 and Adjusts Earnings Guidance for the Year 2024

Nu Skin Introduces MYND360™, a New Line of Clinically Proven Supplements and Topicals for Mental Well-Being

Nu Skin Enterprises, Inc. to Report Q3, 2024 Results on Nov 07, 2024

Nu Skin Enterprises Appoints Mark A. Zorko to its Board of Directors and Audit Committee and Nominating and Corporate Governance Committee

Upcoming dividend of US$0.06 per share

New minor risk - Share price stability

New major risk - Revenue and earnings growth

Nu Skin Enterprises, Inc. Revises Financial Guidance for the Full Year of 2024

Nu Skin Enterprises, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Insufficient new directors

Upcoming dividend of US$0.06 per share

First quarter dividend of US$0.06 announced

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Second Quarter of 2024

First quarter 2024 earnings released: US$0.011 loss per share (vs US$0.23 profit in 1Q 2023)

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on June 12, 2024

Now 21% undervalued after recent price drop

Nu Skin Enterprises, Inc., Annual General Meeting, Jun 05, 2024

Nu Skin Enterprises, Inc. to Report Q1, 2024 Results on May 08, 2024

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 22% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 22%

Fourth quarter dividend of US$0.06 announced

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on March 6, 2024

Nu Skin Enterprises, Inc. to Report Q4, 2023 Results on Feb 14, 2024

Upcoming dividend of US$0.39 per share at 8.8% yield

Independent Director recently sold €254k worth of stock

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2023

Third quarter 2023 earnings released: US$0.74 loss per share (vs US$0.51 loss in 3Q 2022)

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on December 6, 2023

Nu Skin Enterprises, Inc. to Report Q3, 2023 Results on Nov 01, 2023

New minor risk - Insider selling

Upcoming dividend of US$0.39 per share at 6.4% yield

Nu Skin Enterprises, Inc. Provides Earnings Outlook for the Third Quarter and Full-Year 2023

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on September 6, 2023

Second quarter 2023 earnings released: EPS: US$0.54 (vs US$0.68 in 2Q 2022)

Nu Skin Enterprises, Inc. Appoints James D. Thomas as Chief Financial Officer

Nu Skin Enterprises, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Nu Skin Enterprises, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Nu Skin Enterprises, Inc.(NYSE:NUS) dropped from Russell 2000 Growth Index

Upcoming dividend of US$0.39 per share at 4.2% yield

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Second Quarter and Full Year Ended March 31, 2023

First quarter 2023 earnings released: EPS: US$0.23 (vs US$0.77 in 1Q 2022)

Nu Skin Enterprises Announces Quarterly Dividend, Payable on June 7, 2023

Chief Accounting Officer recently sold €110k worth of stock

Full year 2022 earnings released: EPS: US$2.10 (vs US$2.93 in FY 2021)

Nu Skin Enterprises, Inc. Announces Dividend Increase, Payable on March 8, 2023

Nu Skin Enterprises, Inc. to Report Q4, 2022 Results on Feb 15, 2023

Nu Skin Enterprises, Inc.(NYSE:NUS) dropped from S&P 400 Consumer Staples (Sector)

Nu Skin Enterprises Introduces the Next Generation of Smart Skincare with ageLOC LumiSpa iO

Upcoming dividend of US$0.39 per share

Third quarter 2022 earnings released: US$0.51 loss per share (vs US$0.99 profit in 3Q 2021)

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

Nu Skin Enterprises, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Chief Accounting Officer recently sold €63k worth of stock

Insider recently sold €254k worth of stock

Upcoming dividend of US$0.39 per share

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2022

Second quarter 2022 earnings released: EPS: US$0.68 (vs US$1.18 in 2Q 2021)

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on September 7, 2022

Nu Skin Enterprises, Inc. Provides Revenue Guidance for the Second Quarter of 2022

Executive Chairman of the Board recently sold €955k worth of stock

Upcoming dividend of US$0.39 per share

First quarter 2022 earnings released: EPS: US$0.77 (vs US$0.94 in 1Q 2021)

Nu Skin Enterprises Announces Quarterly Dividend, Payable on June 8, 2022

Nu Skin Enterprises, Inc. to Report Q1, 2022 Results on May 04, 2022